Explorer
Covaxin demonstrates protection against deadly new variants
A study published by Clinical Infectious Diseases found that vaccination with Covaxin produced neutralising titres against all key emerging variants tested including B1617 and B117, first identified in India and the UK, respectively.
A modest reduction in neutralization by a factor of 1.95 was observed against B1617 variant compared to vaccine variant.
India
STUDENT PROTEST: Nursing Students’ Agitation Intensifies in Bhopal, Schoolchildren Protest in Uttarakhand
NATIONAL: Amit Shah Hoists Tricolour Under ‘Har Ghar Tiranga’ Campaign
POLITICAL MESSAGE: SPP MPs Deposit ₹2.15 Lakh Collected During Parliament Protest at Hanuman Temple
PARLIAMENT: Lathicharge Row Triggers Uproar in Parliament Complex
BIG REVELATION: Air India Pilot’s Drug Test Sparks Major Aviation Safety Questions
View More
Trending News



















